Biocartis Group Debt 2025

Biocartis Group Aktienanalyse

What does Biocartis Group do?

Biocartis Group NV is a Belgian biotechnology company specializing in the development and marketing of innovative diagnostic test systems. The company was founded in 2007 and is headquartered in Mechelen, Belgium. Biocartis focuses on various disease areas such as gynecology, oncology, infectious diseases, and immunology. Biocartis' business model is based on a unique diagnostic test system called Idylla, which allows for rapid testing within hours instead of the usual weeks. The Idylla platform also offers high accuracy in identifying biomarkers and easy handling for medical personnel. The company has certified distribution partners worldwide to support the marketing and sales of Biocartis products. Biocartis collaborates closely with pharmaceutical companies, medical laboratories, and clinics globally to deliver the best results for its customers. The company also has partnerships with other biotech companies like Merck and Genomic Health to support the development of its diagnostic tests. Biocartis offers a wide range of diagnostic tests for various cancer types, gynecology, and infectious diseases. Their tests help physicians identify the type and extent of tumors and monitor patients' health status. Through the development and marketing of innovative diagnostic test systems, Biocartis aims to improve disease diagnosis and monitoring, ultimately enhancing treatment for patients worldwide. Overall, Biocartis is a leading company in the biotechnology industry specializing in the development and marketing of innovative diagnostic test systems for various disease areas. With its certified distribution partners and partnerships with other biotech companies, Biocartis has a strong presence in the global market and is well positioned to continue being a key player in the biomedical diagnostics industry. Biocartis Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Biocartis Group's Debt Structure

Biocartis Group's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Biocartis Group's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Biocartis Group’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Biocartis Group’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Biocartis Group stock

What is the debt of Biocartis Group this year?

Biocartis Group has a debt level of 71.31 EUR this year.

What was the debt of Biocartis Group compared to the previous year?

The debt of Biocartis Group has increased by 0% compared to the previous year dropped.

What are the consequences of high debt for investors in Biocartis Group?

High debt can pose a risk for investors of Biocartis Group, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Biocartis Group?

Low debt means that Biocartis Group has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Biocartis Group affect the company?

An increase in debt of Biocartis Group can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Biocartis Group affect the company?

A reduction in debt of Biocartis Group can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Biocartis Group?

Some factors that can influence the debt of Biocartis Group include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Biocartis Group so important for investors?

The debts of Biocartis Group are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Biocartis Group take to change the debt?

To change the debt, Biocartis Group can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Biocartis Group pay?

Over the past 12 months, Biocartis Group paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Biocartis Group is expected to pay a dividend of 0 EUR.

What is the dividend yield of Biocartis Group?

The current dividend yield of Biocartis Group is .

When does Biocartis Group pay dividends?

Biocartis Group pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Biocartis Group?

Biocartis Group paid dividends every year for the past 0 years.

What is the dividend of Biocartis Group?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Biocartis Group located?

Biocartis Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Biocartis Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Biocartis Group from 2/21/2025 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 2/21/2025.

When did Biocartis Group pay the last dividend?

The last dividend was paid out on 2/21/2025.

What was the dividend of Biocartis Group in the year 2024?

In the year 2024, Biocartis Group distributed 0 EUR as dividends.

In which currency does Biocartis Group pay out the dividend?

The dividends of Biocartis Group are distributed in EUR.